Answers are grounded in this paper and cite their sources.
Cohort study evaluates angiopoietin-2's role in sedative depth for ARDS patients, suggesting significant implications for sedation practices.
Introduction: Angiopoietin-2 (ANG2) is a protein released from endothelial cells in response to inflammation and injury. Elevated plasma ANG2 indicates endothelial dysfunction and is associated with hepatic and extrahepatic dysfunction and blood-brain barrier permeability. Both hepatic and endothelial barrier dysfunction could influence the response to sedatives and opioids commonly used in critically ill patients. This study evaluated if ANG2 modifies the association of sedatives with resultant sedation depth. Methods: A prospective 2-hospital cohort study enrolled adults with acute respiratory distress syndrome (ARDS) receiving mechanical ventilation for < 5 days and fentanyl or propofol infusion. Plasma ANG2 was measured at enrollment and every 12±4 h for 3 days using ELISA, and sedation depth was assessed via the Richmond Agitation-Sedation Scale (RASS) just prior to each sample collection. Data are presented as mean (±SD) or effect estimate 95% CI. Linear mixed models were developed to evaluate the interaction of sedative and ANG2 on sedation depth. The relationship of ANG2 with time to extubation was evaluated via Cox proportional hazards models treating death as a Fine-Gray competing risk. ANG2 was entered on the log scale in all models. P < 0.05 was considered statistically significant. Results: 66 patients were included. The mean age was 60±14 years and RASS was -4±2 at enrollment. 44 (67%) received propofol at a rate of 33±19 mcg/kg/min and 52 (79%) received fentanyl at a rate of 110±95 mcg/h on the day of enrollment. In a parsimonious linear mixed model entering RASS as the dependent variable, the interaction for propofol with ANG2 was significant (p=0.047), indicating the effect of propofol dose on depth of sedation was dependent on ANG2. After adjusting for fentanyl dose and Sequential Organ Failure Assessment, the effect of propofol dose on sedation depth remained dependent on ANG2 (p=0.02). Lighter sedation was associated with faster time to extubation independent of illness severity and ANG2 (HR 1.25, 95%CI 1.04-1.49; p=0.02). Conclusions: ANG2 influenced the effect of propofol on sedation depth even after adjusting for fentanyl dose and degree of organ dysfunction. Lighter sedation, in turn, was associated with earlier extubation.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: